Biggest News Aggregation in the World
๐Ÿ“ฐ Jun Ma News

Page 4 - Jun Ma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Jun Ma. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Income level impacts tumor recurrence and survival in women with ER-positive breast cancer

Patients with early-stage estrogen receptor-positive breast cancer who live in low-income neighborhoods are likelier to have more-aggressive tumors and significantly lower overall survival (OS) than those in higher-income neighborhoods, according to research led by Roswell Park Comprehensive Cancer Center.
Jun Ma Anurag Singh Emily Henderson Roswell Park Comprehensive Cancer Center Cancer Research Industry National Cancer Database

Junshi Biosciences Announces Updated Clinical data from Phase I study of anti-BTLA antibody Tifcemalimab in Treatment of Relapsed/Refractory Lymphomas at 64th ASH Annual Meeting

Junshi Biosciences Announces Updated Clinical data from Phase I study of anti-BTLA antibody Tifcemalimab in Treatment of Relapsed/Refractory Lymphomas at 64th ASH Annual Meeting - read this article along with other careers information, tips and advice on BioSpace
United States San Francisco Jun Ma Junshi Bioscience Jun Zhu Junshi Biosciences

Investegate |Junshi Biosciences Announcements | Junshi Biosciences: Junshi Biosciences Announces Updated Clinical data from Phase I study of anti-BTLA antibody Tifcemalimab in Treatment of Relapsed/Refractory Lymphomas at 64th ASH Annual Meeting

Investegate announcements from Junshi Biosciences, Junshi Biosciences Announces Updated Clinical data from Phase I study of anti-BTLA antibody Tifcemalimab in Treatment of Relapsed/Refractory Lymphomas at 64th ASH Annual Meeting
United States San Francisco Jun Ma Junshi Bioscience Jun Zhu Junshi Biosciences

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science